logo

For the Inventor, By the Inventor

Winston-Salem, NC, United States of America

Jennifer L R Freeman

This inventor holds 6 USPTO granted patents. Top assignees: Vtv Therapeutics LLC, Transtech Pharma, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer L R Freeman. Retrieved from https://idiyas.com/inventor/jennifer-l-r-freeman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal4 out of 54 
 
Vtv Therapeutics LLC
 patents
silverMedal2 out of 49 
 
Transtech Pharma, Inc.
 patents

Years Active: 2013-2024

Loading Chart...
6 patents (USPTO):Explore Patents
1. 11974989 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2024-05-07),
2. 11833136 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2023-12-05),
3. 10952993 - Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs (2021-03-23),
4. 9175003 - Substituted azoanthracene derivatives and intermediates for preparation thereof (2015-11-03),
5. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2015-03-24),
6. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2013-02-26),

Title: The Innovations of Inventor Jennifer L R Freeman

Introduction

Jennifer L R Freeman is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of diabetes. With a total of 6 patents to his name, Freeman's work focuses on the therapeutic uses of glucokinase activators.

Latest Patents

Freeman's latest patents include innovative methods for using glucokinase (GK) activators in combination with insulin or insulin analogs. These methods are particularly aimed at treating type 1 diabetes. The patents disclose the administration of GK activators alongside insulin, providing new avenues for treatment. Additionally, the patents cover the uses of GK activators as a medicament and the manufacturing processes for such uses.

Career Highlights

Throughout his career, Freeman has worked with various companies, including VTV Therapeutics LLC and Transtech Pharma, Inc. His experience in these organizations has contributed to his expertise in developing medical solutions.

Collaborations

Freeman has collaborated with notable coworkers such as Maria Carmen Valcarce Lopez and Adnan M M Mjalli. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Jennifer L R Freeman's contributions to medical innovation, particularly in diabetes treatment, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…